Bay Area scientists say they’re one step closer to engineering cure for COVID-19


There’s new hope from a group of Bay Area scientists who have been working around the clock to find a cure for COVID-19.

Dr. Jacob Glanville, president and CEO of Distributed Bio, and its therapeutics spin-out, Centivax, is developing an antibody therapeutic to treat the novel coronavirus. He says his team is now one step closer to finding a cure.

Three independent laboratories, including one at Stanford University, have now confirmed that multiple Centivax antibodies previously used in treating SARS, are potent neutralizers of COVID-19. Viral neutralization means that the antibodies are able to completely block the novel coronavirus from infecting human cells.

Glanville added: “We definitely need vaccines, but they take a good amount of time to develop and you can’t give them to those who are already sick because vaccines often take four, five, or six weeks to take effect.”

The initial laboratory results are encouraging to many infectious disease experts who emphasize that any possible cure or vaccine will need to be safely scaled for maximum reach.

“We think this virus can be conquered and we think we have the technology to do it,” said Dr. Yvonne Maldonado, a professor at Stanford University School of Medicine. “We just need to be very careful in making sure that the products that are made are safe.” US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.